Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
No Thumbnail Available
Authors
Author (Corporation)
Publication date
26.04.2016
Typ of student thesis
Course of study
Collections
Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
ACS Nano
Special issue
DOI of the original publication
Link
Series
Series number
Volume
10
Issue / Number
4
Pages / Duration
3886-3899
Patent number
Publisher / Publishing institution
American Chemical Society
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
Recent research has demonstrated that all body fluids assessed contain substantial amts. of vesicles that range in size from 30 to 1000 nm and that are surrounded by phospholipid membranes contg. different membrane microdomains such as lipid rafts and caveolae. The most prominent representatives of these so-called extracellular vesicles (EVs) are nanosized exosomes (70-150 nm), which are derivs. of the endosomal system, and microvesicles (100-1000 nm), which are produced by outward budding of the plasma membrane. Nanosized EVs are released by almost all cell types and mediate targeted intercellular communication under physiol. and pathophysiol. conditions. Contg. cell-type-specific signatures, EVs have been proposed as biomarkers in a variety of diseases. Furthermore, according to their phys. functions, EVs of selected cell types have been used as therapeutic agents in immune therapy, vaccination trials, regenerative medicine, and drug delivery. Undoubtedly, the rapidly emerging field of basic and applied EV research will significantly influence the biomedicinal landscape in the future. In this Perspective, we, a network of European scientists from clin., academic, and industry settings collaborating through the H2020 European Cooperation in Science and Technol. (COST) program European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), demonstrate the high potential of nanosized EVs for both diagnostic and therapeutic (i.e., theranostic) areas of nanomedicine.
Keywords
extracellular vesicles, nanomedicine
Subject (DDC)
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
1936-0851
1936-086X
1936-086X
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
License
Citation
LIPPS, Georg, 2016. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS Nano. 26 April 2016. Bd. 10, Nr. 4, S. 3886–3899. DOI 10.1021/acsnano.5b08015. Verfügbar unter: http://hdl.handle.net/11654/23404